ALTI-PRAZOSIN-TAB 5MG 5 MG
PRAZOSIN (PRAZOSIN HYDROCHLORIDE) : 5 MG · DIN 02139995 · ALTIMED PHARMA INC.
Health Canada status: CANCELLED POST MARKET
What is ALTI-PRAZOSIN-TAB 5MG?
ALTI-PRAZOSIN-TAB 5MG 5 MG contains PRAZOSIN (PRAZOSIN HYDROCHLORIDE) : 5 MG. It is listed in the Health Canada Drug Product Database under DIN 02139995, held by ALTIMED PHARMA INC., supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 27-May-2005. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02139995 |
|---|---|
| Brand name | ALTI-PRAZOSIN-TAB 5MG |
| Generic / active ingredient | PRAZOSIN (PRAZOSIN HYDROCHLORIDE) : 5 MG |
| Manufacturer | ALTIMED PHARMA INC. |
| Strength | 5 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | C02CA01 PRAZOSIN |
| AHFS class | 28:12.92 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 27-May-2005 |
| Original market date | 1998-01-19 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code C02CA01 PRAZOSIN. 6 of 21 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| APO-PRAZO | 1 MG | TABLET | APOTEX INC | MARKETED | DIN 00882801 |
| APO-PRAZO | 2 MG | TABLET | APOTEX INC | MARKETED | DIN 00882828 |
| APO-PRAZO | 5 MG | TABLET | APOTEX INC | MARKETED | DIN 00882836 |
| TEVA-PRAZOSIN | 1 MG | TABLET | TEVA CANADA LIMITED | MARKETED | DIN 01934198 |
| TEVA-PRAZOSIN | 2 MG | TABLET | TEVA CANADA LIMITED | MARKETED | DIN 01934201 |
| TEVA-PRAZOSIN | 5 MG | TABLET | TEVA CANADA LIMITED | MARKETED | DIN 01934228 |
| ALTI-PRAZOSIN-TAB 1MG | 1 MG | TABLET | ALTIMED PHARMA INC. | CANCELLED POST MARKET | DIN 02139979 |
| ALTI-PRAZOSIN-TAB 2MG | 2 MG | TABLET | ALTIMED PHARMA INC. | CANCELLED POST MARKET | DIN 02139987 |
| MINIPRESS | 1 MG | TABLET | AA PHARMA INC | DORMANT | DIN 00560952 |
| MINIPRESS | 2 MG | TABLET | AA PHARMA INC | DORMANT | DIN 00560960 |
Who else supplies PRAZOSIN worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. PRAZOSIN appears in 36 registered pack listings across 4 markets, published on 4 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.